Tuesday, October 30, 2007

Regenerative Medicine for multiple sclerosis

2007 Adult Mesenchymal Stem Cells In Regenerative Medicine ...
The National Center for Regenerative Medicine for Stem Cell and Regenerative ... and neurodegenerative diseases and injuries such as multiple sclerosis. ...

Scientists Find New Causes For Neurodegeneration - By UM Scientists
By Md Moshiur Rahman(Md Moshiur Rahman)
In the normal tissue the cells are tightly packed with no gaps, but in the mutant there are large holes due to loss of neurons from absence of the molecule PI(3,5)P2 from suppression of the Vac14 gene. (Credit: Image courtesy of ...
Today and Tomorrow - http://lhctoday.blogspot.com/

Scientists find new causes for neurodegeneration
By squiffy2
The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. Lipids are a group of small organic compounds. While the best studied lipids are fats, waxes and oils, PI3,5P2 is a member of a unique class of lipids that signal ...
BrainTalk Communities - http://brain.hastypastry.net/forums

Scientists Find New Causes For Neurodegeneration
By Fausto Intilla (fisico teorico)(Fausto Intilla (fisico teorico))
The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. Lipids are a group of small organic compounds. While the best studied lipids are fats, waxes and oils, PI3,5P2 is a member of a unique class of lipids that signal ...
Health & Medicine - News & Press... - http://healthmedicinenewsandpress.blogspot.com/

Multiple Sclerosis Resource Centre Latest MS News
Latest MS News Page providing up to the date breaking Multiple Sclerosis news ... The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. ...

Scientists find new causes for neurodegeneration - BrainTalk ...
The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. ... Squiffy's House of Fun - Laughter for Multiple Sclerosis ...

Scientists discover new causes for neurodegeneration
Weisman said it was surprising to find that PI(3,5)P2 plays a key role in the survival ... The signaling lipid PI(3,5)P2 (short for phosphatidylinositol 3 ...

New Causes For Neurodegeneration Discovered By U-M Scientists ...
The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. ... The signaling lipid PI(3,5)P2 (short for phosphatidylinositol 3,5-bisphosphate) ...

Field,SJ
Interference with PtdIns(4,5)P2 interferes with adhesion of the plasma .... By examining various mutants, we show that synthesis of PI(3,4,5)P3 in S. pombe ...

FirstScience - U-M scientists find new causes for neurodegeneration
The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. Lipids are a group of small organic compounds. While the best studied lipids are ...

New Causes For Neurodegeneration Discovered By U-M Scientists
The signaling lipid PI(3,5)P2 (short for phosphatidylinositol 3 .... Alzheimer's / Dementia · CJD / vCJD / Mad Cow Disease · Multiple Sclerosis ...

Scientists find new causes for neurodegeneration | Huliq
Simple eye scan opens window to multiple sclerosis ... Weisman said it was surprising to find that PI(3,5)P2 plays a key role in the survival of nervous ...

Hiller Amyotrophic Lateral Sclerosis Center - Publications
Mutation of FIG4 encoding a PI(3,5)P2 phosphatase causes neurodegeneration in the pale tremor mouse and in patients with CMT type 4G. ...

Health & Medicine - News & Press (健康與醫學新聞出版)
The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. .... We can insert multiple genes into it to enhance its tumor-killing capabilities ...

Disability Happens » Alzheimer's discovery involves little known lipid
The molecule is PI(3,5)P2 and is a lipid that is found in all cells at very low levels ... Multiple Sclerosis (MS), and Creutzfeldt-Jakob (Mad Cow Disease). ...

Scientists find new causes for neurodegeneration
The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. ... Weisman said it was surprising to find that PI(3,5)P2 plays a key role in the ...

Genzyme Gets It Together
On the R&D front, Genzyme reported positive phase 2 data in multiple sclerosis patients for a formulation of already-marketed leukemia drug Campath. Genzyme and partner Bayer now have the anti-MS version of Campath in two phase 3 studies; if successful, that could put approval somewhere in the 2011 time frame. It's still too early to tell how the drug will fare competitively, though. The strong efficacy data seen thus far has been tempered somewhat with a few moderate safety issues.
http://www.fool.com/investing/high-growth/2007/10/29/genzyme-gets-it-together.aspx
Close Failure for Genzyme
… Unfortunately, with the results that Genzyme (Nasdaq: GENZ) published today for its drug Campath for MS, this appears to be the case. …
www.fool.com/.../2006/09/14/close-failure-for-genzyme.aspx - September 14, 2006

Genzyme Gets It Together
… On the R&D front, Genzyme reported positive phase 2 data in multiple sclerosis patients for a formulation of already-marketed leukemia drug Campath. …
www.fool.com/.../2007/10/29/genzyme-gets-it-together.aspx - October 29, 2007

BEYOND study: Results do not support regulatory filing for ...
PharmaLive.com (press release) - Newtown,PA,USA
Bayer Schering Pharma expects sales of Betaferon® to grow in the range of 7-9 percent in 2007 and 2008. The company's continued investment in lifecycle ...
See all stories on this topic

Positive Development Of BB BIOTECH-share In The 3rd Quarter
ABN Newswire (press release) - Sydney,NSW,Australia
At the same time, the visibility of the sales potential of important drugs such as Biogen Idec's Tysabri or Celgene's Revlimid improved and triggered ...
See all stories on this topic

Teva Third-Quarter Net Falls as US Drug Sales Drop (Update2)
Bloomberg - USA
US regulators decided to allow Elan Corp. and Biogen Idec Inc. to resume sales of their Tysabri MS drug in June 2006. Sales of Tysabri shot up more than ...
See all stories on this topic

Positive development of BB
Ad-Hoc-News (Pressemitteilung) - Germany
Atthe same time, the visibility of the sales potential of importantdrugs such as Biogen Idec's Tysabri or Celgene's Revlimid improvedand triggered ...
See all stories on this topic

_______________________________

Acne Medication May Delay Progress Of Multiple Sclerosis, Canada
Medical News Today (press release) - UK
A common acne medication that has been available for over 30 years has the potential to delay the progress of multiple sclerosis and if proven effective, ...
See all stories on this topic

Acne drug being enlisted to battle MS
Toronto Star - Ontario, Canada
In the five years she's been taking the acne drug minocycline to control her multiple sclerosis, it's the first time the medication has failed her on either ...
See all stories on this topic

Study to probe whether acne drug can slow MS
CTV.ca - Canada
... acne medication could help delay the crippling effects of multiple sclerosis. The medication, called minocycline, has been available for over 30 years. ...
See all stories on this topic

A good pill to swallow for MS?
Canoe.ca (subscription) - Toronto,Ontario,Canada
... the crippling effects of multiple sclerosis. A $4-million clinical trial begins next year to test the effectiveness of the common acne drug minocycline ...
See all stories on this topic

Acne Medication May Delay Progress Of Multiple Sclerosis, Canada
A common acne medication that has been available for over 30 years has the potential to delay the progress of multiple sclerosis and if proven effective, will offer an inexpensive option for the treatment of early MS, says the MS Society of Canada.

______________________________

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home